FOIL's $20-$22 IPO is one day from NYSE trading; no retail allocation verified
Londian Wason's FOIL IPO reaches its final pre-listing checkpoint on August 11: the terms are public, the offer price is still pending, and no mainstream-broker IPO allocation is verified.
Tuesday, August 11, 2026 is a regular NYSE trading day. The practical takeaway: FOIL is a listing watch for tomorrow, not a verified retail IPO allocation today. No mainstream-broker subscription window met the public checks for this edition. 1
Today's spotlight: Londian Wason New Energy Tech (FOIL)
Status: Watch only. IPOX lists FOIL for NYSE trading on August 12. The offering is about 3.57 million ADSs at $20-$22, with each ADS representing five ordinary shares. At the $21 midpoint, the deal would raise about $75 million and imply a market value of roughly $1.6 billion. Webull still showed the offering price as pending when its IPO page was retrieved. 23
Business in one sentence: Londian Wason makes electrolytic copper foil used in lithium-ion batteries, printed-circuit boards, energy storage systems and electric vehicles. Its named customers include CATL, BYD, LG Energy Solution, Samsung SDI and Panasonic. 4
Why retail investors care: This is a direct battery-supply-chain bet, not a broad clean-energy label. The company says it supplied about 111,985 metric tons of lithium-ion battery copper foil in 2025 and held a 7.6% global share, ranking first by sales volume in the Frost & Sullivan data cited in its IPO profile. 4
Demand signal: Investors led by Harvest Fund Management indicated interest in about $87 million of ADSs, or roughly 115% of the midpoint offering. That is an indication of interest, not a completed purchase and not a promise of a strong first trading day. 5
Risk to monitor: Customer concentration. Reuters reported that FOIL's growth and profitability have improved, but investors will be watching its reliance on a few large customers. A lost customer, weaker battery demand or delayed expansion could matter more for a concentrated supplier than for a diversified manufacturer. 6
Minimum buy-in and broker access: The $20-$22 range is an IPO price range, not a verified retail minimum. No public allocation notice through Robinhood, Fidelity, Schwab, E*TRADE or Webull was verified in the reviewed public sources. If FOIL appears in a brokerage app after listing, that is ordinary market trading—not proof that the $20 IPO was available to that account.
Actionable now
No US IPO allocation met all four checks for this edition: public offer terms, a live deadline, a minimum buy-in and a verified path through a mainstream retail broker. Calendar and exchange pages can confirm an IPO or listing event, but they do not establish that a retail investor can subscribe. 78
| Ticker | Price range | Minimum buy-in | Deadline | Verified brokers | Status |
|---|---|---|---|---|---|
| None verified | — | Not disclosed | No public allocation window found | None publicly verified | Watch only |
Market pulse
- FOIL is the week's clearest non-biotech demand test. Its $87 million of indicated interest is larger than the $75 million midpoint deal, but the final price and first trading session will tell you more than the headline indication. 5
- The broader IPO basket is ahead of the broad market so far in 2026. As of August 6, the Renaissance IPO Index was up 18.6% year to date, versus 13.4% for the S&P 500. That is a favorable backdrop, not a guarantee for a single debut. 5
- Biotech demand remains selective but real. BlossomHill raised $150 million versus an initial target of about $111.7 million, while Latigo raised $345.6 million versus a planned $247.2 million. Both deals were described as oversubscribed; the signal is strong demand for selected stories, not a blanket bid for every new issue. 9
HK desk
No Hong Kong public subscription is open or closing by August 12 in the current public timetable. ET Net's August 11 IPO page shows no related information under listing IPOs. NASN TECH is already a completed listing, so its heavily subscribed offer is a result to watch, not an application available today. 10
On the radar: August 11-24
| Deal | Pricing date | Expected listing | Terms | Why watch |
|---|---|---|---|---|
| Londian Wason New Energy Tech (FOIL) | Not disclosed; offer price pending | Aug. 12, NYSE | 3.57M ADSs at $20-$22 | Battery-material exposure, a 7.6% reported global share, and indicated demand above the midpoint deal. 24 |
| Lyntris (LYNX) | Not disclosed | Aug. 19, NYSE | 24M shares at $19-$22; about $492M at the midpoint | Defense-tech connectivity with sensor hardware, data software and military customers; the deal moved from an unpriced filing to a sizable marketed IPO. 11 |
The current public calendars reviewed did not disclose a separate pricing date for LYNX or another dated traditional US company IPO inside this window. That keeps the radar short rather than filling it with undated filings, funds or warrant events. 7
Market information only, not investment advice. IPO terms, dates and access can change before a final prospectus, pricing or listing.
References
- 1NYSE holidays and trading hours
nyse.com
- 2Londian Wason IPOX profile
ipox.com
- 3FOIL IPO page
webull.com
- 4Londian Wason IPO profile
renaissancecapital.com
- 5US IPO Week Ahead
renaissancecapital.com
- 6Reuters on Londian Wason's IPO
reuters.com
- 7Renaissance Capital IPO calendar
renaissancecapital.com
- 8NYSE IPO filings
nyse.com
- 9Fierce Biotech on BlossomHill and Latigo
fiercebiotech.com
- 10ET Net IPO page
etnet.com.hk
- 11Lyntris IPO profile
iposcoop.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.